A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection-Reference-Cited by-同舟云学术

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection

Published:2013-04-15 Issue:5 Volume:62 Page:483-486
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Rockstroh Jürgen K.,DeJesus Edwin,Henry Keith,Molina Jean-Michel,Gathe Joseph,Ramanathan Srinivasan,Wei Xuelian,Plummer Andrew,Abram Michael,Cheng Andrew K.,Fordyce Marshall W.,Szwarcberg Javier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference8 articles.

1. . Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.;Sax;Lancet,2012

2. . Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.;DeJesus;Lancet,2012

3. . Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function.;German;J Acquir Immune Defic Syndr,2012

4. . Once-daily darunavirritonavir vs. lopinavirritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis.;Mills;AIDS,2009

5. . Raltegravir versus efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.;Lennox;J Acquir Immune Defic Syndr,2010

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weight and Metabolic Outcomes in Naïve HIV Patients Treated with Integrase Inhibitor-Based Antiretroviral Therapy: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2023-05-24

2. Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients;Viruses;2023-05-08

3. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

4. Comparison of Renal Function Biomarkers of Serum Creatinine and Cystatin C in HIV-Infected People on Dolutegravir-Containing Therapy;Infection and Drug Resistance;2022-04

5. Effects of different integrase strand transfer inhibitors on body weight in patients with HIV/AIDS: a network meta-analysis;BMC Infectious Diseases;2022-02-03